Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

9478	Companies
185482	Keywords
117825	Articles
99322	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 11/25/2024 at 16:05, 1 year ago

Jaguar Health to Present at Two Upcoming Conferences

Pharmaceuticals Jaguar Health Lisa Conte Conference Presentation Gastrointestinal Medicine
PRESS RELEASE

published on 11/25/2024 at 16:00, 1 year ago

Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference
Jaguar Health, Inc. to present at NobleCon20 and Emerging Growth Conference. Lisa Conte to present on December 3 and virtually on December 5, 2024. Jaguar focuses on gastrointestinal distress medicines

Pharmaceuticals Jaguar Health Lisa Conte Emerging Growth Conference NobleCon20
BRIEF

published on 11/22/2024 at 14:50, 1 year ago

Jaguar Health Seeks Partner for Dog Diarrhea Drug NP300

FDA Approval Jaguar Health NP300 Dog Diarrhea Pet Connect Conference
PRESS RELEASE

published on 11/22/2024 at 14:45, 1 year ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Jaguar Health, Inc. announces extension of FDA approval for Canalevia®-CA1 for chemotherapy-induced diarrhea in dogs, seeks partner for NP300 development at Pet Connect conference

Jaguar Health Diarrhea Veterinary NP300 Canalevia®-CA1
BRIEF

published on 11/19/2024 at 15:35, 1 year ago

Napo Therapeutics Awarded "Best Pharmaceuticals Innovator of the Year - Europe"

Crofelemer Awards Rare Diseases Napo Therapeutics Innovative Pharmaceuticals
PRESS RELEASE

published on 11/19/2024 at 15:30, 1 year ago

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe”
Jaguar Health's Napo Therapeutics awarded 'Best Pharmaceuticals Innovator of the Year - Europe' for expanding access to crofelemer in Europe for orphan and rare diseases. Partnering with Jaguar and Napo Pharmaceuticals for clinical studies

Crofelemer Jaguar Health Rare Diseases Orphan Diseases Napo Therapeutics
BRIEF

published on 11/13/2024 at 14:05, 1 year ago

Jaguar Health Reports Strong Q3 2024 Financial Performance

Financial Results Crofelemer Jaguar Health Q3 2024 Cancer Supportive Care
PRESS RELEASE

published on 11/13/2024 at 14:00, 1 year ago

Jaguar Health Reports Third Quarter 2024 Financial Results
Jaguar Health, Inc. reports a 14% revenue increase in Q3 2024, introduces Gelclair commercial launch. Initiates Phase 2 trials and IIT studies. Hosts investor webcast on November 13

Revenue Increase Jaguar Health Q3 2024 Phase 2 Trials Gelclair
BRIEF

published on 11/11/2024 at 14:35, 1 year ago

Jaguar Health to Discuss Q3 2024 Financials in Upcoming Investor Webcast

Napo Pharmaceuticals Crofelemer Investor Webcast Jaguar Health Q3 Financials
PRESS RELEASE

published on 11/11/2024 at 14:30, 1 year ago

Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) to conduct investor webcast on November 13, 2024 at 8:30 a.m. Eastern to review Q3 2024 financials and provide corporate updates

Investor Webcast Jaguar Health Corporate Updates Q3 Financials NASDAQ:JAGX

Accesswire

Published on 12/05/2025 at 15:25, 13 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 38 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 38 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 38 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 13 hours 3 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:05, 33 minutes ago

Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 16 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 21 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 28 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 53 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings

Les Echos

Published on 12/05/2025 at 15:10, 27 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 6 hours 53 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 21 hours 38 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 53 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 54 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

View all LES ECHOS COMFI WIRE